These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 10679091)
1. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. Lord JD; McIntosh BC; Greenberg PD; Nelson BH J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091 [TBL] [Abstract][Full Text] [Related]
2. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. Lord JD; McIntosh BC; Greenberg PD; Nelson BH J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391 [TBL] [Abstract][Full Text] [Related]
3. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632 [TBL] [Abstract][Full Text] [Related]
4. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. Martino A; Holmes JH; Lord JD; Moon JJ; Nelson BH J Immunol; 2001 Feb; 166(3):1723-9. PubMed ID: 11160217 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. Moon JJ; Nelson BH J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615 [TBL] [Abstract][Full Text] [Related]
6. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704 [TBL] [Abstract][Full Text] [Related]
7. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Gesbert F; Griffin JD Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976 [TBL] [Abstract][Full Text] [Related]
8. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. Nelson BH; Martyak TP; Thompson LJ; Moon JJ; Wang T J Immunol; 2003 Jun; 170(11):5563-70. PubMed ID: 12759434 [TBL] [Abstract][Full Text] [Related]
9. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278 [TBL] [Abstract][Full Text] [Related]
10. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain. Delespine-Carmagnat M; Bouvier G; Bertoglio J Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027 [TBL] [Abstract][Full Text] [Related]
11. An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival. Ciprés A; Gala S; Martinez-A C; Mérida I; Williamson P Eur J Immunol; 1999 Apr; 29(4):1158-67. PubMed ID: 10229082 [TBL] [Abstract][Full Text] [Related]
12. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786 [TBL] [Abstract][Full Text] [Related]
13. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654 [TBL] [Abstract][Full Text] [Related]
14. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase. Morcinek JC; Weisser C; Geissinger E; Schartl M; Wellbrock C Oncogene; 2002 Mar; 21(11):1668-78. PubMed ID: 11896598 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780 [TBL] [Abstract][Full Text] [Related]
16. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. Ascherman DP; Migone TS; Friedmann MC; Leonard WJ J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. Chida D; Wakao H; Yoshimura A; Miyajima A Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603 [TBL] [Abstract][Full Text] [Related]
19. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. Antov A; Yang L; Vig M; Baltimore D; Van Parijs L J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638 [TBL] [Abstract][Full Text] [Related]
20. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Nakajima H; Liu XW; Wynshaw-Boris A; Rosenthal LA; Imada K; Finbloom DS; Hennighausen L; Leonard WJ Immunity; 1997 Nov; 7(5):691-701. PubMed ID: 9390692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]